This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Flovent disappeared Jan. 1, when GSK pulled it. Insurers dropping coverage and Medicaid rule changes likely incentivized the move to protect profits.
GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.
